COUGH AND RUB

咳嗽和摩擦

• 批准号: 7951307
• 负责人: IAN A. PAUL
• 金额: $ 0.14万
• 依托单位: PENNSYLVANIA STATE UNIV HERSHEY MED CTR
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-01 至 2010-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7951307
• 关键词: Acute; Affect; Caring; Child; Clinical Research; Computer Retrieval of Information on Scientific Projects Database; Coughing; Funding; Grant; Guidelines; Institution; Left; Ointments; Oral; Parents; Patients; Petrolatum; Publishing; Research; Research Personnel; Resources; Sleep; Source; Symptoms; Therapeutic; United States; United States National Institutes of Health; Upper Respiratory Infections; Visit; treatment effect

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Cough is the most common reason for an acute care doctor's visit in the United States and may be the most bothersome symptom for children with upper respiratory tract infections (URI). It is particularly troublesome at night because it can adversely affect sleep for both coughing children and their parents. Recent studies and published guidelines have questioned the efficacy of many of the oral over-the-counter treatments for cough and cold symptoms. This has left parents and patients with limited therapeutic options. This study seeks to subjectively evaluate whether Vicks¿ VapoRub¿ (VVR) ointment and a control ointment (petrolatum) are better than no treatment at all for controlling nocturnal cough and cold symptoms in children with URI. It also will determine the effect of the treatments on sleep quality for children with URI and their parents.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以出现在其他 CRISP 条目中 列出的机构是。 中心，不一定是研究者的机构。 在美国，咳嗽是急症护理医生就诊的最常见原因，并且可能是患有上呼吸道感染 (URI) 的儿童最令人烦恼的症状，这在夜间尤其麻烦，因为它会对咳嗽的孩子的睡眠产生不利影响。最近的研究和发布的指南对许多口服非处方药治疗咳嗽和感冒症状的疗效提出了质疑，这使得父母和患者的治疗选择有限。 VapoRub¿ (VVR) 软膏和对照软膏（凡士林）对于控制 URI 儿童夜间咳嗽和感冒症状比不治疗要好。它还将决定治疗对 URI 儿童及其父母睡眠质量的影响。